DNMT3A and lymphoma: In the meantime, sequencing of non-lymphoma controls’ CSF cfDNA showed no mutation in five, insufficient cfDNA in two, and DNMT3A c.1851+1G>A mutation (VAF 0.9%) in one (CONTROL-5).